The Consulting Team at Latham BioPharm Group specializes in providing strategic insights and tailored solutions for clients in the life sciences sector. Leveraging extensive industry knowledge and a robust network, the team collaborates with clients to optimize product development, streamline operations, and enhance market strategies, ensuring alignment with evolving industry trends and regulatory requirements.
Allen Duplantier
Principal Consultant II
Daniel Signa
Principal Consultant I
Gervan Williams
Senior Consultant
Ivan Silva
Principal Consultant I
Jim Beltzer
Principal Consultant I
Keith DeDonder
Principal Consultant
Patrick Falvey
Principal Consultant II
Rachel Schmitz
Senior Consultant
Robert Huebner
Principal Consultant III
Thijs Beuming
Principal Consultant I
View all